ALK rearrangements are uncommon but actionable oncogenic drivers in non–small cell lung cancer.
Hong Zheng, MM
Advertisement
Articles by Hong Zheng, MM
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Reading a Changed Eye Examination and Impact on Therapy
2
FDA Expands Approval for Nogapendekin Alfa in BCG-Unresponsive NMIBC
3
VS-7375 Yields Responses in KRAS G12D–Mutated Solid Tumors
4
Operationalizing the First Dose and Building the Oncology and Eye Care Partnership
5